胶质瘤-星形胶质细胞连接蛋白43通过激活E2F1/ERCC1轴介导替莫唑胺耐药
本研究探讨肿瘤相关星形胶质细胞与胶质瘤细胞间连接蛋白43(Cx43)介导替莫唑胺(TMZ)耐药的机制。通过肿瘤样本、临床数据库、基因敲低与Gfap-Cre Cx43flox/flox小鼠及生化实验发现,Cx43上调促进TMZ耐药与复发,敲低或药理抑制Cx43可增强TMZ细胞毒性。机制上Cx43升高使β-连环蛋白在胶质瘤细胞表面积聚,抑制TCF/LEF转录,降低miR-205-5p并激活E2F1/ERCC1轴导致耐药。
要点
- 肿瘤相关星形胶质细胞与胶质瘤细胞间Cx43表达上调参与TMZ耐药和肿瘤复发。
- 基因敲低或药理抑制Cx43可增强TMZ诱导的细胞毒性。
- Cx43/miR-205-5p/E2F1/ERCC1轴是TMZ耐药的新调控机制,靶向Cx43具治疗潜力。
核心结论
- Cx43/miR-205-5p/E2F1/ERCC1轴参与胶质瘤TMZ耐药,靶向Cx43可能是胶质瘤治疗策略。
研究设计与样本
- 在肿瘤样本与临床数据库中评估Cx43表达及预后价值,并用ShRNA介导的敲低和Gfap-Cre Cx43flox/flox基因小鼠在体外和体内评估Cx43的作用与功能意义。
- 采用质谱分析、染色质免疫沉淀及其他生化实验明确Cx43促进TMZ耐药的分子机制。
主要发现
- 肿瘤相关星形胶质细胞与胶质瘤细胞之间Cx43表达上调促进TMZ耐药和肿瘤复发。
- 基因敲低或药理抑制Cx43增强TMZ诱导的细胞毒性。
- Cx43表达升高诱导β-连环蛋白在胶质瘤细胞表面积聚,抑制T细胞因子/淋巴增强结合因子转录。
- 上述改变导致miR-205-5p表达受损,随后激活E2F1/ERCC1轴,最终导致化疗耐药。
临床怎么用
- 作者认为靶向Cx43可能是胶质瘤的治疗策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Glioma is the most prevalent and lethal tumor of the central nervous system. Routine treatment with temozolomide (TMZ) would unfortunately result in inevitable recurrence and therapy resistance, severely limiting therapeutic efficacy. Tumor-associated astrocytes (TAAs) are key components of the tumor microenvironment and increasing evidence has demonstrated that aberrant expression of connexin43 (Cx43) was closely associated with glioma progression and TMZ resistance. However, the specific role of Cx43 in mediating TMZ resistance through glioma and astrocyte interactions has not been fully explored. METHODS: The expression and prognostic value of Cx43 were evaluated in tumor samples and clinical databases. ShRNA-medicated knockdown and Gfap-Cre Cx43flox/flox gene mouse were used to assess the role and functional significance of Cx43 in vitro and in vivo. Moreover, we performed mass spectrometry analysis, chromatin immunoprecipitation, and other biochemical assays to define the molecular mechanisms by which Cx43 promotes TMZ resistance. RESULTS: We confirmed that the upregulation of Cx43 expression between TAAs and glioma cells contributed to TMZ resistance and tumor recurrence. Genetic knockdown or pharmacological inhibition of Cx43 enhanced TMZ-induced cytotoxicity. Mechanistically, elevated Cx43 expression induced β-catenin accumulation at the cell surface of glioma cells, suppressing T-cell factor/lymphoid enhancer-binding factor transcription. This led to impaired miR-205-5p expression and subsequent activation of the E2F1/ERCC1 axis, which eventually led to chemoresistance. CONCLUSIONS: Our study reveals a novel regulatory mechanism in which the Cx43/miR-205-5p/E2F1/ERCC1 axis contributes to TMZ resistance in glioma. These findings further highlight the potential of targeting Cx43 as a therapeutic strategy in glioma.
引用
- Gui Y, Qin H, Zhang X, et al. Glioma-astrocyte connexin43 confers temozolomide resistance through activation of the E2F1/ERCC1 axis. Neuro Oncol. 2025. PMID: 39514365. doi:10.1093/neuonc/noae237
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。